Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$10.17 - $12.64 $2.22 Million - $2.76 Million
-218,698 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$10.88 - $17.05 $414,832 - $650,082
-38,128 Reduced 14.85%
218,698 $2.74 Million
Q4 2020

Feb 02, 2021

BUY
$9.23 - $18.18 $154,380 - $304,078
16,726 Added 6.97%
256,826 $4.01 Million
Q3 2020

Nov 05, 2020

BUY
$9.38 - $12.48 $66,598 - $88,608
7,100 Added 3.05%
240,100 $2.27 Million
Q2 2020

Aug 12, 2020

SELL
$6.21 - $11.83 $7,452 - $14,196
-1,200 Reduced 0.51%
233,000 $2.09 Million
Q1 2020

May 12, 2020

SELL
$5.05 - $8.85 $24,240 - $42,480
-4,800 Reduced 2.01%
234,200 $1.49 Million
Q4 2019

Jan 27, 2020

BUY
$8.03 - $11.7 $381,424 - $555,750
47,500 Added 24.8%
239,000 $2 Million
Q3 2019

Oct 31, 2019

BUY
$9.05 - $12.22 $722,190 - $975,156
79,800 Added 71.44%
191,500 $1.73 Million
Q2 2019

Aug 15, 2019

SELL
$8.75 - $13.03 $151,637 - $225,809
-17,330 Reduced 13.43%
111,700 $1.2 Million
Q1 2019

May 03, 2019

SELL
$7.72 - $12.81 $24,704 - $40,992
-3,200 Reduced 2.42%
129,030 $1.23 Million
Q4 2018

Feb 08, 2019

BUY
$9.51 - $16.6 $258,672 - $451,520
27,200 Added 25.9%
132,230 $1.52 Million
Q3 2018

Nov 13, 2018

SELL
$13.05 - $19.05 $92,655 - $135,255
-7,100 Reduced 6.33%
105,030 $1.78 Million
Q2 2018

Aug 15, 2018

SELL
$13.9 - $19.8 $318,754 - $454,053
-22,932 Reduced 16.98%
112,130 $1.59 Million
Q1 2018

May 11, 2018

SELL
$16.7 - $26.35 $236,689 - $373,458
-14,173 Reduced 9.5%
135,062 $2.57 Million
Q4 2017

Feb 06, 2018

BUY
$11.6 - $17.35 $405,246 - $606,122
34,935 Added 30.56%
149,235 $2.45 Million
Q3 2017

Nov 15, 2017

BUY
$8.4 - $15.0 $960,120 - $1.71 Million
114,300
114,300 $1.72 Million

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $136M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.